The antiphospholipid syndrome (APS) is a systemic autoimmune disorder characterized,
according to the Sydney criteria, by the persistent presence of autoantibodies directed …

Antiphospholipid antibody (aPL)-associated thrombophilia has been implicated in various
adverse pregnancy outcomes, including preterm birth and impaired fetal development. This …

Antiphospholipid syndrome (APS) is an acquired highly prothrombotic disorder in which
thrombo-inflammatory antiphospholipid antibodies (aPL) cause thrombosis via multiple …

Proteins in the plasma/serum mirror an individual's physiology. Circulating extracellular
vesicles (EVs) proteins constitute a large portion of the plasma/serum proteome. Thus, deep …

Background Antiphospholipid syndrome (APS) is a multisystemic autoimmune disorder
characterized by thrombotic events and/or gestational morbidity in patients with …

Antiphospholipid syndrome (APS), characterized by artherial and/or venous thrombosis,
pregnancy morbidity and “antiphospholipid” antibodies (aPLs), is more common in women …

Antiphospholipid syndrome (APS) is a systemic autoimmune condition characterised by the
presence of antiphospholipid antibodies (aPL) associated with vascular thrombosis and/or …

As an important functional protein molecule in the human body, human annexin A5
(hAnxA5) is widely found in human cells and body fluids. hAnxA5, the smallest type of …

Antiphospholipid syndrome (APS) is characterized by venous or arterial thrombosis and/or
adverse pregnancy outcome in the presence of persistent laboratory evidence of …

Context: Implementation of pre-conception care units is still very limited in Italy. Nowadays,
the population's awareness of the reproductive risks that can be reduced or prevented is …